India Glycols Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The India Glycols Q2 results FY27 announcement is the next scheduled earnings event for India Glycols Ltd., India Glycols manufactures specialty chemicals, ethylene oxide derivatives, and bio-based glycols used in industrial, personal care, and food applications.. The stock traded at Rs 266.20 on the NSE on 16 September 2026, down 5.00% from the previous close of Rs 280.20, about 15.8% below its 52-week high of Rs 316.30 and 66.0% above its 52-week low of Rs 160.37.

What makes the India Glycols Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 1,092.00 crore of revenue and a profit of Rs 65.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 1,130.00 crore and a profit of Rs 97.00 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the India Glycols Q2 Results FY27 Date?

The India Glycols Q2 results date for FY27 is not confirmed. As of 16 September 2026, India Glycols Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the India Glycols Q2 results date becomes public through that filing rather than through any advance announcement.

Also read – Gujarat Fluorochemicals Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The India Glycols Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for India Glycols.

India Glycols Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the India Glycols Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for India Glycols. The India Glycols Q2 results watchlist below is built from what the company has actually reported and disclosed.

India Glycols Q2 results are entering focus as the company heads into its next earnings print, and the five-quarter revenue trend gives useful context for India Glycols Q2 results watchers. Revenue moved from Rs 1,040 crore in the June 2025 quarter to Rs 1,092 crore in the September 2025 quarter, Rs 1,102 crore in December 2025, then dipped to Rs 976 crore in March 2026, before rebounding to Rs 1,130 crore in the June 2026 quarter. This shows demand for the company's specialty chemicals and glycol derivatives holding up despite one seasonally weaker quarter. Heading into the September 2026 quarter, the question for India Glycols Q2 results followers is whether this Rs 1,130 crore run rate can be sustained.

Alongside the India Glycols Q2 results revenue story, operating margin has trended higher across the five quarters, from 14% in June 2025 and September 2025 to 16% in December 2025 and 17% in March 2026, before easing to 15% in June 2026. Operating profit rose from Rs 150 crore to Rs 170 crore over this period. Net profit has moved less smoothly: Rs 73 crore in June 2025, Rs 65 crore in September 2025, Rs 68 crore in December 2025, then a jump to Rs 87 crore in March 2026 and Rs 97 crore in June 2026. This late acceleration in net profit is one of the more important threads for India Glycols Q2 results coverage this cycle, alongside the margin trend itself.

Ahead of India Glycols Q2 results, on valuation the company trades at a stock P/E of about 5.65, well below many chemical peers, against a book value of Rs 438 per share and a price-to-book ratio near 0.61. Return on equity is 11.3% and return on capital employed is 12.4%, with a dividend yield of about 2.81%. A large part of the recent net profit growth traces to a sharp fall in interest expense, from roughly Rs 45-49 crore per quarter between June 2025 and December 2025 down to about Rs 25-26 crore in March 2026 and June 2026, pointing to debt reduction rather than a purely operating gain. As the September 2026 quarter approaches, this interest cost trend is likely to matter more than the base chemicals business itself. Anyone reading India Glycols Q2 results coverage should treat this balance-sheet-driven tailwind separately from core margins, note the unusually low other income in December 2025, and remember that India Glycols Q2 results deserve a closer read than the low P/E alone suggests.

Check India Glycols Ltd. Live Fundamentals on the Univest Screener

India Glycols Q2 Results Preview: The Q1 FY27 Actuals It Builds On

India Glycols Ltd. reported revenue of Rs 1,130.00 crore in Q1 FY27, up 8.65% from Rs 1,040.00 crore in Q1 FY26, and a profit of Rs 97.00 crore at the net level, up 32.88% from Rs 73.00 crore in Q1 FY26. These are reported actuals, not estimates.

Also read – Gabriel India Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

Sequentially, revenue was up 15.78% over the March 2026 quarter figure of Rs 976.00 crore, and net profit was up 11.49% from Rs 87.00 crore in Q4 FY26. Operating margin stood at 14.0% in Q1 FY27 against 14.0% in the September 2025 quarter, which is the comparison the India Glycols Q2 results print will be read against.

Q2 FY26 Base: The Comparison India Glycols Q2 Results FY27 Must Beat

India Glycols Ltd. reported revenue of Rs 1,092.00 crore and a profit of Rs 65.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this India Glycols Q2 results preview.

Net profit in that base quarter was below the Rs 97.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 1,092.00 crore sits below the Rs 1,130.00 crore of the June 2026 quarter, which frames how much sequential movement the India Glycols Q2 results print needs to show growth.

India Glycols Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	1,092.00	65.00
Q3 FY26 (Dec 2025)	1,102.00	68.00
Q4 FY26 (Mar 2026)	976.00	87.00
Q1 FY27 (Jun 2026)	1,130.00	97.00

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this India Glycols Q2 results preview uses.

Revenue across those four quarters ranged from Rs 976.00 crore to Rs 1,130.00 crore, and net profit from Rs 65.00 crore to Rs 97.00 crore. That spread is the honest context for the India Glycols Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape India Glycols Q2 Results FY27

The India Glycols Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what India Glycols has already reported.

Valuation Snapshot

India Glycols currently trades at a stock P/E of roughly 5.63 to 5.65, notably lower than many specialty chemical peers. Book value stands at Rs 438 per share, putting the price-to-book ratio at about 0.61, meaning the stock trades below its book value. Return on equity is 11.3% and return on capital employed is 12.4%, both reasonable for the sector. The dividend yield is around 2.81%. While the low P/E might look attractive on the surface, the debt-reduction-driven profit growth noted above means the multiple should be read alongside underlying operating trends rather than taken as a standalone cheap signal.

Technical and Price Context

India Glycols shares are currently trading around Rs 266-267, below the 52-week high of Rs 316.3 but well above the 52-week low of Rs 160.37. The stock is trading above both its 50-day moving average of Rs 247.0 and its 200-day moving average of Rs 216.2, indicating the price sits above its recent and longer-term trend lines. The Relative Strength Index reads about 52.6, which is in a neutral zone, neither overbought nor oversold. The stock has pulled back from recent levels, down about 5% in the latest session, placing it in the middle portion of its 52-week trading range.

Balance Sheet and Payout

India Glycols carries a debt-to-equity ratio of about 0.58, a moderate level for a manufacturing business of this size. The dividend yield stands at approximately 2.81%, reflecting a consistent payout policy. As flagged above, interest expense has fallen sharply since March 2026, from the Rs 45-49 crore per quarter range down to roughly Rs 25-26 crore, consistent with a reduction in borrowings or refinancing at better terms. This debt reduction trend has directly supported recent profit-before-tax and net profit growth, and it is a balance-sheet factor worth tracking separately from the company's day-to-day operating performance.

India Glycols Q2 Results FY27: Share Price and Valuation Going Into the Print

India Glycols share price today is Rs 266.20 on the NSE, down Rs 14.00 or 5.00% from the previous close of Rs 280.20 on 16 September 2026, ahead of the India Glycols Q2 results announcement.

Metric	Value (16 September 2026)
NSE Symbol	INDIAGLYCO
Current Market Price	Rs 266.20
52-Week High	Rs 316.30
52-Week Low	Rs 160.37
Market Capitalisation	Rs 1784 crore
PE Ratio	5.63
PB Ratio	0.61
EPS (TTM)	Rs 47.26
Book Value per Share	Rs 438.00
Debt to Equity	0.58
Return on Equity	11.3%
50-Day Moving Average	Rs 247.00
200-Day Moving Average	Rs 216.20
RSI (14)	52.60

The stock trades above both its 50-day average of Rs 247.00 and its 200-day average of Rs 216.20, with a 14-day RSI of 52.60. None of this is a view on where the shares go once the India Glycols Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track India Glycols Ltd. live price and quarterly earnings updates.

What Investors Should Watch When India Glycols Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the India Glycols Q2 results print in proportion.

1. Revenue against the Rs 1,092.00 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 65.00 crore in that same quarter
3. Operating margin against 14.0% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the India Glycols Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on India Glycols Q2 Results FY27

The India Glycols Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. India Glycols Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the India Glycols Q2 results FY27 print faces a base of Rs 1,092.00 crore in revenue and a profit of Rs 65.00 crore, with the most recent quarter having delivered Rs 1,130.00 crore and a profit of Rs 97.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for India Glycols, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on India Glycols Q2 Results FY27

What is the India Glycols Q2 results date for FY27?

Ans. The India Glycols Q2 results date for FY27 is not confirmed. India Glycols Ltd. had not filed a board meeting intimation with the NSE or BSE as of 16 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the India Glycols Q2 results 2026 cover?

Ans. The India Glycols Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. India Glycols Ltd. reports revenue, operating profit and net profit for that period, and the India Glycols Q2 results filing also carries the notes to the accounts.

What were the India Glycols Q1 FY27 results?

Ans. India Glycols Ltd. reported revenue of Rs 1,130.00 crore in Q1 FY27 and a profit of Rs 97.00 crore at the net level. Revenue was up 8.65% versus Q1 FY26 and net profit was up 32.88% from Rs 73.00 crore in Q1 FY26.

What were India Glycols Q2 FY26 results in the September 2025 quarter?

Ans. India Glycols Ltd. reported revenue of Rs 1,092.00 crore and a profit of Rs 65.00 crore in Q2 FY26. Operating margin was 14.0%. Those figures form the base for the India Glycols Q2 results FY27 comparison.

What are the main India Glycols Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The India Glycols Q2 results expectations centre on revenue against the Rs 1,092.00 crore base, net profit against a profit of Rs 65.00 crore, operating margin against 14.0% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is India Glycols share price today ahead of the Q2 earnings?

Ans. India Glycols share price is Rs 266.20 on the NSE as of 16 September 2026, down 5.00% from Rs 280.20. The stock is about 15.8% below its 52-week high of Rs 316.30 and 66.0% above its 52-week low of Rs 160.37, at a market capitalisation of Rs 1784 crore.

Is India Glycols a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on India Glycols Ltd. The stock trades at a price-to-book ratio of 0.61 with a return on equity of 11.3%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.